US Stock MarketDetailed Quotes

MIRM Mirum Pharmaceuticals

Watchlist
  • 46.640
  • -0.010-0.02%
Trading Nov 29 10:31 ET
2.24BMarket Cap-22423P/E (TTM)

About Mirum Pharmaceuticals Company

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Company Profile

SymbolMIRM
Company NameMirum Pharmaceuticals
Listing DateJul 18, 2019
Issue Price15.00
Founded2018
CEOMr. Christopher Peetz
MarketNASDAQ
Employees264
Fiscal Year Ends12-31
Address989 East Hillsdale Boulevard,Suite 300
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-667-4085
Websitehttp://www.mirumpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Christopher Peetz
  • Director and Chief Executive Officer
  • 6.45M
  • Dr. Pamela Vig, PhD
  • Chief Scientific Officer
  • --
  • Dr. Joanne Quan, M.D.
  • Chief Medical Officer
  • --
  • Eric H. Bjerkholt
  • Chief Financial Officer
  • 4.34M
  • Lara Longpre, PhD
  • Chief Development Officer
  • --
  • Peter Radovich
  • Chief Operating Officer and President
  • 2.37M
  • Michael Grey
  • Chairman of the Board
  • 451.75K
  • Dr. Lon Cardon, PhD
  • Independent Director
  • 194.47K
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 411.75K
  • Laura A. Brege
  • Independent Director
  • 426.75K
  • Timothy P. Walbert
  • Independent Director
  • 671.53K
  • Patrick J. Heron
  • Independent Director
  • 401.75K
  • Dr. Laurent Fischer, M.D.
  • Independent Director
  • 421.75K
  • William Carl Fairey
  • Independent Director
  • 411.75K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data